Hamburg, Wednesday 16 August 2017 10.22 CST
Digital therapy is radically reshaping the healthcare landscape for a number of key reasons: Well-developed digital therapeutics can be as effective as chemical compounds. Distribution and production costs are very low. In addition, real life data are collected from every patient on the program.
GAIA is the global leading developer of digital therapeutics with over 10 years of R&D experience. Over 7.000 patients have been studied in RCT´s in the area of Neurology, Immunology and Diabetes.
Register now for our webinar to take advantage of this strategic opportunity for your organization.